Broadcom's revenue from artificial intelligence chips is poised to take off remarkably in the next few years.

Executives from Contineum Therapeutics (NASDAQ:CTNM) outlined the company’s clinical priorities and upcoming catalysts during a presentation at the Leerink Global Healthcare Conference, emphasizing a ...